MannKind Corp (NASDAQ:MNKD)
| 1.56 Delayed Data As of 4:00pm ET |  +0.05 / +3.31%Today’s Change | 1.02 Today|||52-Week Range 2.34 | +20.93% Year-to-Date |
Latest MNKD News | Press Releases
No recent news for MannKind Corp.
Today’s Trading
| Previous close | 1.51 |
| Today’s open | 1.53 |
| Day’s range | 1.51 - 1.69 |
| Volume | 4,937,032 |
| Average volume (3 months) | 2,434,810 |
| Market cap | $301.4M |
Data as of 4:00pm ET, 02/21/2020
Growth & Valuation
| Earnings growth (last year) | +46.60% |
| Earnings growth (this year) | +56.25% |
| Earnings growth (next 5 years) | +31.60% |
| Revenue growth (last year) | +137.20% |
| P/E ratio | NM |
| Price/Sales | 5.48 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ADROAduro Biotech Inc | -0.22 | -5.68% |
| ISEEIveric Bio Inc | -0.25 | -3.94% |
| HOOKHOOKIPA Pharma Inc | +0.02 | +0.17% |
| AMAGAMAG Pharmaceuticals... | +0.08 | +0.85% |
Data as of 4:00pm ET, 02/21/2020
Financials
| Next reporting date | February 26, 2020 |
| EPS forecast (this quarter) | -$0.07 |
| Annual revenue (last year) | $27.9M |
| Annual profit (last year) | -$87.0M |
| Net profit margin | -312.20% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Westlake Village, California |
Forecasts
